Sign inGet started

Munsie Jeffrey A

Insider CIK 1703041 · MACK General Counsel · CNCE Chief Legal Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CNCE CONCERT PHARMACEUTICALS, I D To issuer deriv2023-03-062023-03-0651,850— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I D To issuer deriv2023-03-062023-03-0642,430— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I D To issuer deriv2023-03-062023-03-06100,000— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I D To issuer2023-03-062023-03-0649,699— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I U Tender2023-03-062023-03-0638,350— $00SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2023-02-152023-02-163,762$8.34 $31.4K88,049SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2023-01-302023-01-318,493$8.35 $70.9K91,811SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2023-01-062023-01-092,893$7.25 $21.0K100,304SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2022-02-142022-02-163,762$3.09 $11.6K103,197SEC↗
CNCE CONCERT PHARMACEUTICALS, I A Award2022-01-282022-02-0163,700— $0106,959SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2022-01-052022-01-072,894$3.20 $9.3K43,259SEC↗
CNCE CONCERT PHARMACEUTICALS, I S Sale2021-02-162021-02-173,763$7.32 $27.5K46,153SEC↗
CNCE CONCERT PHARMACEUTICALS, I A Award deriv2021-01-052021-01-0751,850— $051,850SEC↗
CNCE CONCERT PHARMACEUTICALS, I A Award2021-01-052021-01-0721,700— $049,916SEC↗
CNCE CONCERT PHARMACEUTICALS, I A Award deriv2020-02-142020-02-1942,430— $042,430SEC↗
CNCE CONCERT PHARMACEUTICALS, I A Award2020-02-142020-02-1928,216— $028,216SEC↗
CNCE CONCERT PHARMACEUTICALS, I A Award deriv2019-09-262019-09-27100,000— $0100,000SEC↗
MACK MERRIMACK PHARMACEUTICALS A Award deriv2018-12-112018-12-1345,000— $045,000SEC↗
MACK MERRIMACK PHARMACEUTICALS A Award deriv2018-02-152018-02-1645,000— $045,000SEC↗
MACK MERRIMACK PHARMACEUTICALS A Award deriv2017-06-062017-06-07550,000— $0550,000SEC↗